Skip to main content

RegMedNet is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Our journals
    • Our journals
    • Journal content
    • Journal articles

    Follow us on social media

  • Topics
    • CAR-T
      • Stem cells
      • Cell therapy
      • Gene therapy
      • Gene editing
    • Cancer
      • Preclinical research
      • Tissue engineering
      • 3D printing
      • Biobanking
    • Clinical trials & funding
      • Manufacturing & scale-up
      • Regulation & policy
      • Industry developments

    Follow us on social media

  • Explore content
    • News
      • The week in cell therapy
      • Interviews
      • Opinion
      • Report
      • App Notes & White Papers
      • Spotlights
      • In Focus
    • eBooks
      • Webinars
      • Podcasts
      • Videos
      • Infographics
      • Find a partner
      • Events
      • Events coverage
      • The Glossary for Advanced Therapies

    Follow us on social media

  • Register
Spotlight exclusive: Expert insights on GMP media, xeno-free solutions and raw material management Read the interview!

Welcome to RegMedNet

26 JUN 2026 CELL THERAPY
US$7.49 grant awarded to develop off-the-shelf CAR-NKT cell therapy for multiple sclerosis
25 JUN 2026 CANCER
Immune signatures could explain CAR-T response in glioblastoma
25 JUN 2026 INDUSTRY DEVELOPMENTS
Cell therapy weekly: nanoparticle platform for targeted gene therapy
24 JUN 2026 CELL THERAPY
Oxford Nanopore sequencing solutions for cell and gene therapies
23 JUN 2026
Viral and non-viral gene delivery approaches
23 JUN 2026 GENE EDITING
eBook | Viral and non-viral gene delivery approaches
1 / 6

Sign up for our RegMedNet weekly news round-up

16 JUN 2026 AWARENESS / ARTICLE
World Sickle Cell Day 2026: current progress and developments
4 JUN 2026 STEM CELLS / ARTICLE
Exploring MSC-derived exosomes for tissue repair and regeneration
3 JUN 2026 CLINICAL MANUFACTURING / ARTICLE
Cost-effectiveness analysis favors stem cell transplantation over gene therapy for sickle cell patients